The insulin resistance phenotype (muscle or liver) interacts with the type of diet to determine changes in disposition index after 2 years of intervention: the CORDIOPREV-DIAB randomised clinical trial

Diabetologia

Volumn 59, Issue 1, 2016, Pages 67-76

  Blanco Rojo, Ruth ^a,b,c,d   Alcala Diaz, Juan F ^a,b,c,d   Wopereis, Suzan ^e   Perez Martinez, Pablo ^a,b,c,d   Quintana Navarro, Gracia M ^a,b,c,d   Marin, Carmen ^a,b,c,d   Ordovas, Jose M ^f,g   van Ommen, Ben ^e   Perez Jimenez, Francisco ^a,b,c,d   Delgado Lista, Javier ^a,b,c,d   Lopez Miranda, Jose ^a,b,c,d  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

^d Instituto de Salud Carlos III   (Spain)

^e TNO   (Netherlands)

^f TUFTS UNIVERSITY   (United States)

^g IMDEA FOOD INSTITUTE   (Spain)

Author keywords

Beta cell function; Dietary intervention; Insulin resistance; Low fat diet; Mediterranean diet

Indexed keywords

INSULIN; OLIVE OIL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC DIET; DIETARY INTAKE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; NUTRITIONAL ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

EID: 84949318780     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3776-4     Document Type: Article

References (38)

1. World Health Organization (2008) 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases: prevent and control cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. WHO, Geneva
2. DeFronzo RA (2010) Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53:1270–1287
3. Matthaei S, Stumvoll M, Kellerer M, Haring HU (2000) Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 21:585–618
4. Weir GC, Bonner-Weir S (2004) Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53(Suppl 3):S16–S21
5. Salas-Salvado J, Martinez-Gonzalez MA, Bullo M, Ros E (2011) The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis 21(Suppl 2):B32–B48
6. Lopez-Miranda J, Perez-Jimenez F, Ros E et al (2010) Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008. Nutr Metab Cardiovasc Dis 20:284–294
7. Salas-Salvado J, Bullo M, Babio N et al (2011) Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34:14–19
8. American Diabetes Association (2014) Standards of medical care in diabetes—2014. Diabetes Care 37(Suppl 1):S14–S80
9. Goodpaster BH, Coen PM (2012) Do acute exercise and diet reveal the molecular basis for metabolic flexibility in skeletal muscle? Diabetes 61:983
10. Tiikkainen M, Hakkinen AM, Korsheninnikova E, Nyman T, Makimattila S, Yki-Järvinen H (2004) Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 53:2169–2176
11. Garcia-Rios A, Gomez-Delgado FJ, Garaulet M et al (2014) Beneficial effect of CLOCK gene polymorphism rs1801260 in combination with low-fat diet on insulin metabolism in the patients with metabolic syndrome. Chronobiol Int 31:401–408
12. Perez-Martinez P, Alcala-Diaz JF, Delgado-Lista J et al (2014) Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis. Eur J Clin Invest 44:1053–1064
13. Portaluppi F, Smolensky MH, Touitou Y (2010) Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int 27:1911–1929
14. Fernandez-Ballart JD, Pinol JL, Zazpe I et al (2010) Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr 103:1808–1816
15. Estruch R, Ros E, Salas-Salvadó J et al (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368:1279–1290
16. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470
17. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89–94
18. Song Y, Manson JE, Tinker L et al (2007) Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women’s Health Initiative Observational Study. Diabetes Care 30:1747–1752
19. Hanson RL, Pratley RE, Bogardus C et al (2000) Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151:190–198
20. Tang W, Fu Q, Zhang Q et al (2014) The association between serum uric acid and residual beta -cell function in type 2 diabetes. J Diabetes Res 2014:709691
21. Abdul-Ghani MA, Matsuda M, DeFronzo RA (2008) Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects. Diabet Med 25:1289–1294
22. Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544
23. Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350
24. Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403
25. Schwingshackl L, Missbach B, Konig J, Hoffmann G (2014) Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis. Public Health Nutr: 1-8
26. Esposito K, Chiodini P, Maiorino MI, Bellastella G, Panagiotakos D, Giugliano D (2014) Which diet for prevention of type 2 diabetes? A meta-analysis of prospective studies. Endocrine 47:107–116
27. Salas-Salvado J, Bullo M, Estruch R et al (2014) Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial. Ann Intern Med 160:1–10
28. Faerch K, Borch-Johnsen K, Holst JJ, Vaag A (2009) Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia 52:1714–1723
29. Jenkins DJ, Kendall CW, Banach MS et al (2011) Nuts as a replacement for carbohydrates in the diabetic diet. Diabetes Care 34:1706–1711
30. Sleiman D, Al-Badri MR, Azar ST (2015) Effect of Mediterranean diet in diabetes control and cardiovascular risk modification: a systematic review. Front Public Health 3:69
31. Paniagua JA, de la Sacristana AG, Sanchez E et al (2007) A MUFA-rich diet improves postprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr 26:434–444
32. Faerch K, Brons C, Alibegovic AC, Vaag A (2010) The disposition index: adjustment for peripheral vs hepatic insulin sensitivity? J Physiol 588:759–764
33. Mann JI, De Leeuw I, Hermansen K et al (2004) Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14:373–394
34. Hamman RF, Wing RR, Edelstein SL et al (2006) Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 29:2102–2107
35. Snel M, Jonker JT, Schoones J et al (2012) Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol 2012:983814
36. Riserus U, Willett WC, Hu FB (2009) Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 48:44–51
37. Jans A, van Hees AM, Gjelstad IM et al (2012) Impact of dietary fat quantity and quality on skeletal muscle fatty acid metabolism in subjects with the metabolic syndrome. Metabolism 61:1554–1565
38. Sandoval DA, D'Alessio DA (2015) Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease. Physiol Rev 95:513–548